David Chau

David originally trained as a chemical engineer before gaining an interest in biotechnology which resulted in the completion of a BEng and MSc, respectively, from the University of Birmingham. Thereafter, he gained his PhD under the guidance of Professor Martin Griffin (Nottingham Trent/Aston University) in the field of Tissue Engineering and Biomaterials which cumulated in the publication of several papers and the award of a worldwide patent. Following on, David pursued his research interests as a Postdoctoral Research Fellow under Professor Kevin Shakesheff (University of Nottingham) in Tissue Engineering/Advanced Drug Delivery before joining the Cell and Organism Engineering Laboratory of Professor Alan Tunnacliffe (University of Cambridge).

In essence, David's research interests focuses on biotechnology- the application of the life sciences to the fields of engineering, medicine and technology- in particular their application to regenerative medicine and drug delivery.

David's previous research has focused on tissue engineering and biomaterial development with emphasis on skin, the eye and the brain. In contrast, his most recent research has centred upon the development of a desiccation-tolerant mammalian cell line with a view for exploitation in long-term storage and biotechnological applications. David has experience of working at both academia and the industrial interface and maintains an extensive professional network accordingly. David is a firm believer in the concept of “to make things better, you first need to know how it works” and the application of “benchside-to-bedside” technology. As such, he aims to build upon his expertise in tissue engineering and drug delivery to develop more accurate and robust in-vitro-in-vivo-like models that may be exploited for drug development

Regenerative Medicine, Tissue Engineering, Biomaterials, Drug Delivery